RTW Investments’s Centessa Pharmaceuticals CNTA Stock Holding History

RTW Investments’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,054,175	Closed	-$81.6M	–	90
2026 Q1	$81.6M	Buy	2,054,175 +263,338	+15%	+$6.74M	0.81%	34
2025 Q4	$44.8M	Sell	1,790,837 -500,910	-22%	-$12.7M	0.45%	50
2025 Q3	$55.6M	Buy	2,291,747 +761,911	+50%	+$13.5M	0.68%	37
2025 Q2	$20.1M	Buy	1,529,836 +1,479,836	+2,960%	+$18.7M	0.29%	49
2025 Q1	$719K	Hold	50,000	–	–	0.01%	66
2024 Q4	$838K	Hold	50,000	–	–	0.01%	70
2024 Q3	$800K	Buy	+50,000	New	+$613K	0.01%	65

RTW Investments's CNTA Position: Q2 2026 in Review

RTW Investments sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 2,054,175 shares — an estimated $81.6M sold.

RTW Investments first reported a position in CNTA in Q3 2024 and held it in 7 quarters. The position peaked at $81.6M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

RTW Investments reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
RTW Investments sold 2,054,175 Centessa Pharmaceuticals shares in Q2 2026, an estimated $81.6M.
RTW Investments first reported a position in Centessa Pharmaceuticals in Q3 2024 and held it in 7 quarters.
RTW Investments's Centessa Pharmaceuticals position peaked at $81.6M in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on RTW Investments's 13F filing for Q2 2026, filed 14 Aug 2026.